Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

This grant solicits applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. 

Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer biology.

Funding: $400,000 total 

Duration: 3 years

Research Autority due date: 10 days prior to submission 

LOI (encouraged) due dates: 22.1.21, 27.4.21, 29.8.21

Full proposal due dates: 22.2.21, 27.5.21, 29.9.21